These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Engineered peptides corresponding to segments of the H3 domain of syntaxin inhibit insulin release both in intact and permeabilized mouse pancreatic beta cells.
    Author: Martin F, Salinas E, Barahona F, Vázquez J, Soria B, Reig JA.
    Journal: Biochem Biophys Res Commun; 1998 Jul 09; 248(1):83-6. PubMed ID: 9675090.
    Abstract:
    Syntaxin is one of the proteins involved in the exocytotic event through sequential binding to specific proteins, including SNAP25 and synaptobrevin. In a previous work in digitonin-permeabilized beta cells, we characterized the functional role of two segments: synA and synB of the H3 domain of syntaxin. As a continuation of these experiments in the present study we have initially outlined a zone of 17 residues as the very effective uncoupling element of the synA segment. Further functional studies have been accomplished in intact pancreatic beta cells with a specific myristoylated (myr) 13-mer peptide comprised in this active zone. These experiments showed a concentration-dependent inhibition of glucose-induced insulin release (IC50 = 4 microM) of this engineered peptide that was specific since a myristoylated random peptide with the same composition was ineffective. A second myristoylated 13-mer peptide comprised into the synB segment was shown to be even more potent promoting a selective inhibition of insulin release. These data show for the first time, that nutrient-induced secretory process can be specifically uncoupled in intact beta cells demonstrating at the same time that syntaxin plays a central role in this mechanism.
    [Abstract] [Full Text] [Related] [New Search]